Streptococcal toxic shock syndrome involves isolation of group A streptococcus, hypotension, and two other symptoms such as renal impairment. Treatment involves intravenous benzylpenicillin and either clindamycin or lincomycin. For penicillin-allergic patients, cephalothin or cephazolin can be substituted. Staphylococcal toxic shock syndrome resembles streptococcal toxic shock and is toxin-mediated; treatment involves intravenous flucloxacillin or cephalosporins for penicillin-allergic patients. Intravenous immunoglobulin may be considered for toxic shock syndrome with expert advice.
Streptococcal toxic shock syndrome involves isolation of group A streptococcus, hypotension, and two other symptoms such as renal impairment. Treatment involves intravenous benzylpenicillin and either clindamycin or lincomycin. For penicillin-allergic patients, cephalothin or cephazolin can be substituted. Staphylococcal toxic shock syndrome resembles streptococcal toxic shock and is toxin-mediated; treatment involves intravenous flucloxacillin or cephalosporins for penicillin-allergic patients. Intravenous immunoglobulin may be considered for toxic shock syndrome with expert advice.
Streptococcal toxic shock syndrome involves isolation of group A streptococcus, hypotension, and two other symptoms such as renal impairment. Treatment involves intravenous benzylpenicillin and either clindamycin or lincomycin. For penicillin-allergic patients, cephalothin or cephazolin can be substituted. Staphylococcal toxic shock syndrome resembles streptococcal toxic shock and is toxin-mediated; treatment involves intravenous flucloxacillin or cephalosporins for penicillin-allergic patients. Intravenous immunoglobulin may be considered for toxic shock syndrome with expert advice.
- Streptococcal toxic shock is the isolation of a group A streptococcus (Streptococcus
pyogenes), hypotension and 2 of the following: renal impairment, coagulopathy, liver
involvement, adult respiratory distress syndrome, generalised rash or soft tissue necrosis. - Staphylococcal toxic shock syndrome is a toxin-mediated disease which Use: may appear from an apparently minor infection. It resembles streptococcal - benzylpenicillin 1.8 g (child: 45 mg/kg up to 1.8 g) IV, 4-hourly toxic shock syndrome. Aggressive resuscitation and treatment of the source PLUS EITHER are important aspects of therapy. Use: clindamycin 600 mg (child: 15 mg/kg up to 600 mg) IV, 8-hourly streptococcal staphylococcal toxic di/flucloxacillin 2 g (child: 50 mg/kg up to 2 g) IV, 6-hourly. OR lincomycin 600 mg (child: 15 mg/kg up to 600 mg) IV, 8-hourly. toxic shock toxic shock - The addition of clindamycin may stop toxin production although there is no syndrome shock syndrome clinical evidence to support this For patients hypersensitive to penicillin (excluding immediate hypersensitivity), substitute syndrome - For patients hypersensitive to penicillin (excluding immediate hypersensitivity), use: for benzylpenicillin: cephalothin 2 g (child: 50 mg/kg up to 2 g) IV, 6-hourly cephalothin 2 g (child: 50 mg/kg up to 2 g) IV, 6-hourly OR OR cephazolin 2 g (child: 50 mg/kg up to 2 g) IV, 8-hourly. cephazolin 2 g (child: 50 mg/kg up to 2 g) IV, 8-hourly. - In toxic shock syndrome, consider the use of IV immunoglobulin after expert advice: normal immunoglobulin 0.4 to 2 g/kg IV, for 1 or 2 doses during the first 72 hours.